• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于具有多相特征的剂量反应曲线的自动拟合程序和软件。

An automated fitting procedure and software for dose-response curves with multiphasic features.

作者信息

Di Veroli Giovanni Y, Fornari Chiara, Goldlust Ian, Mills Graham, Koh Siang Boon, Bramhall Jo L, Richards Frances M, Jodrell Duncan I

机构信息

CRUK Cambridge Institute, University of Cambridge, UK.

NIH Chemical Genomics Center, National Institutes of Health, Bethesda, USA.

出版信息

Sci Rep. 2015 Oct 1;5:14701. doi: 10.1038/srep14701.

DOI:10.1038/srep14701
PMID:26424192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4589737/
Abstract

In cancer pharmacology (and many other areas), most dose-response curves are satisfactorily described by a classical Hill equation (i.e. 4 parameters logistical). Nevertheless, there are instances where the marked presence of more than one point of inflection, or the presence of combined agonist and antagonist effects, prevents straight-forward modelling of the data via a standard Hill equation. Here we propose a modified model and automated fitting procedure to describe dose-response curves with multiphasic features. The resulting general model enables interpreting each phase of the dose-response as an independent dose-dependent process. We developed an algorithm which automatically generates and ranks dose-response models with varying degrees of multiphasic features. The algorithm was implemented in new freely available Dr Fit software (sourceforge.net/projects/drfit/). We show how our approach is successful in describing dose-response curves with multiphasic features. Additionally, we analysed a large cancer cell viability screen involving 11650 dose-response curves. Based on our algorithm, we found that 28% of cases were better described by a multiphasic model than by the Hill model. We thus provide a robust approach to fit dose-response curves with various degrees of complexity, which, together with the provided software implementation, should enable a wide audience to easily process their own data.

摘要

在癌症药理学(以及许多其他领域)中,大多数剂量-反应曲线都能通过经典的希尔方程(即四参数逻辑方程)得到令人满意的描述。然而,在某些情况下,存在不止一个拐点的明显特征,或者存在激动剂和拮抗剂的联合效应,这使得无法通过标准的希尔方程对数据进行直接建模。在此,我们提出一种改进的模型和自动拟合程序,以描述具有多相特征的剂量-反应曲线。由此产生的通用模型能够将剂量-反应的每个阶段解释为一个独立的剂量依赖性过程。我们开发了一种算法,该算法能自动生成并对具有不同程度多相特征的剂量-反应模型进行排序。该算法已在新的免费软件Dr Fit(sourceforge.net/projects/drfit/)中实现。我们展示了我们的方法如何成功地描述具有多相特征的剂量-反应曲线。此外,我们分析了一个涉及11650条剂量-反应曲线的大型癌细胞活力筛选实验。基于我们的算法,我们发现28%的情况用多相模型描述比用希尔模型更好。因此,我们提供了一种稳健的方法来拟合具有不同复杂程度的剂量-反应曲线,连同所提供的软件实现,应该能使广大用户轻松处理他们自己的数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/33ea39b6a305/srep14701-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/9eac618a8eec/srep14701-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/d20ea1331b1b/srep14701-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/18564285ae90/srep14701-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/791e1ccb080c/srep14701-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/c6d7350bb289/srep14701-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/cedfe6a6a63c/srep14701-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/33ea39b6a305/srep14701-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/9eac618a8eec/srep14701-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/d20ea1331b1b/srep14701-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/18564285ae90/srep14701-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/791e1ccb080c/srep14701-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/c6d7350bb289/srep14701-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/cedfe6a6a63c/srep14701-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/819f/4589737/33ea39b6a305/srep14701-f7.jpg

相似文献

1
An automated fitting procedure and software for dose-response curves with multiphasic features.一种用于具有多相特征的剂量反应曲线的自动拟合程序和软件。
Sci Rep. 2015 Oct 1;5:14701. doi: 10.1038/srep14701.
2
Computational tools for fitting the Hill equation to dose-response curves.用于将希尔方程拟合到剂量反应曲线的计算工具。
J Pharmacol Toxicol Methods. 2015 Jan-Feb;71:68-76. doi: 10.1016/j.vascn.2014.08.006. Epub 2014 Aug 23.
3
Assessing the (a)symmetry of concentration-effect curves: empirical versus mechanistic models.评估浓度-效应曲线的(非)对称性:经验模型与机制模型
Pharmacol Ther. 2002 Jul;95(1):21-45. doi: 10.1016/s0163-7258(02)00223-1.
4
A grid algorithm for high throughput fitting of dose-response curve data.一种用于高通量拟合剂量反应曲线数据的网格算法。
Curr Chem Genomics. 2010 Oct 21;4:57-66. doi: 10.2174/1875397301004010057.
5
Analysis of dose-response curves and calculation of agonist dissociation constants using a weighted nonlinear curve fitting program.使用加权非线性曲线拟合程序分析剂量反应曲线并计算激动剂解离常数。
J Pharmacol Methods. 1983 Dec;10(4):231-41. doi: 10.1016/0160-5402(83)90017-7.
6
A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs.针对细胞周期阶段特异性和非特异性药物的剂量反应曲线的一种机制性预测模型。
Cancer Res. 2000 Mar 1;60(5):1417-25.
7
Calculating slope and ED50 of additive dose-response curves, and application of these tabulated parameter values.计算相加剂量-反应曲线的斜率和半数有效剂量(ED50),以及这些列表参数值的应用。
J Pharmacol Toxicol Methods. 1995 Jun;33(3):137-45. doi: 10.1016/1056-8719(94)00068-f.
8
Recursive model for dose-time responses in pharmacological studies.药物研究中剂量-时间反应的递归模型。
BMC Bioinformatics. 2019 Jun 20;20(Suppl 12):317. doi: 10.1186/s12859-019-2831-4.
9
JSFit: a method for the fitting and prediction of J- and S-shaped concentration-response curves.JSFit:一种用于拟合和预测J形及S形浓度-反应曲线的方法。
RSC Adv. 2018 Feb 9;8(12):6572-6580. doi: 10.1039/c7ra13220d. eCollection 2018 Feb 6.
10
Analysis of asymmetry of agonist concentration-effect curves.激动剂浓度-效应曲线的不对称性分析
J Pharmacol Toxicol Methods. 1999 Apr-Jun;41(2-3):107-15. doi: 10.1016/s1056-8719(99)00026-x.

引用本文的文献

1
A Novel Microencapsulated Bovine Recombinant Interferon Tau Formulation for Luteolysis Modulation in Cattle.一种用于调节牛黄体溶解的新型微囊化牛重组干扰素τ制剂
Biomolecules. 2025 Jul 14;15(7):1009. doi: 10.3390/biom15071009.
2
Detrended fluctuation analysis of heart rate variability during exercise: Time to reconsider the theoretical and methodological background. Comment on: Cassirame et al.`s (2025) Detrended fluctuation analysis to determine physiologic thresholds, investigation and evidence from incremental cycling test. Eur J Appl Physiol 125:523-533.运动期间心率变异性的去趋势波动分析:是时候重新审视其理论和方法学背景了。评论:卡西拉梅等人(2025年)的《通过去趋势波动分析确定生理阈值:递增式自行车测试的研究与证据》。《欧洲应用生理学杂志》125:523 - 533。
Eur J Appl Physiol. 2025 Jul 4. doi: 10.1007/s00421-025-05859-2.
3

本文引用的文献

1
Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion.纳米脂质体伊立替康的临床前活性由肿瘤沉积和肿瘤内前药转化决定。
Cancer Res. 2014 Dec 1;74(23):7003-13. doi: 10.1158/0008-5472.CAN-14-0572. Epub 2014 Oct 1.
2
Computational tools for fitting the Hill equation to dose-response curves.用于将希尔方程拟合到剂量反应曲线的计算工具。
J Pharmacol Toxicol Methods. 2015 Jan-Feb;71:68-76. doi: 10.1016/j.vascn.2014.08.006. Epub 2014 Aug 23.
3
Cytotoxicity of binary mixtures of human pharmaceuticals in a fish cell line: approaches for non-monotonic concentration-response relationships.
Evolution of iGluR ligand specificity, polyamine regulation, and ion selectivity inferred from a placozoan epsilon receptor.从扁盘动物ε受体推断离子型谷氨酸受体配体特异性、多胺调节及离子选择性的进化
Commun Biol. 2025 Jul 3;8(1):994. doi: 10.1038/s42003-025-08402-3.
4
Comparison of various methodological approaches to model asbestos thresholds for mesothelioma.用于模拟间皮瘤石棉阈值的各种方法学途径的比较。
Front Public Health. 2025 May 13;13:1569343. doi: 10.3389/fpubh.2025.1569343. eCollection 2025.
5
Mean plant toxicity modulates the effects of plant defense variability.平均植物毒性调节植物防御变异性的影响。
Ecology. 2025 Feb;106(2):e70012. doi: 10.1002/ecy.70012.
6
Antimicrobial peptide production with Corynebacterium glutamicum on lignocellulosic side streams.利用谷氨酸棒杆菌在木质纤维素副产物上生产抗菌肽。
Biotechnol Biofuels Bioprod. 2024 Dec 18;17(1):147. doi: 10.1186/s13068-024-02587-1.
7
Correlation properties of heart rate variability for exercise prescription during prolonged running at constant speeds: A randomized cross-over trial.在恒定速度下长时间跑步期间的运动处方的心率变异性的相关特性:一项随机交叉试验。
Eur J Sport Sci. 2024 Nov;24(11):1539-1551. doi: 10.1002/ejsc.12175. Epub 2024 Sep 19.
8
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer.基于转化模型的证据表明,在非小细胞肺癌中,标准治疗药物与抗 microRNA-155 联合使用可提高疗效。
Mol Cancer. 2024 Aug 2;23(1):156. doi: 10.1186/s12943-024-02060-5.
9
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer.基于转化模型的证据表明,标准治疗药物与抗微小RNA-155联合使用可提高非小细胞肺癌的疗效。
medRxiv. 2024 Mar 15:2024.03.14.24304306. doi: 10.1101/2024.03.14.24304306.
10
Quantitative and Standardized Pseudovirus Neutralization Assay for COVID-19.用于 COVID-19 的定量和标准化假病毒中和测定法。
Methods Mol Biol. 2024;2779:259-271. doi: 10.1007/978-1-0716-3738-8_11.
二元混合物对鱼类细胞系的细胞毒性:非单调浓度-反应关系的方法。
Chemosphere. 2014 Aug;108:334-42. doi: 10.1016/j.chemosphere.2014.01.077. Epub 2014 Feb 26.
4
Inconsistency in large pharmacogenomic studies.大型药物基因组学研究中的不一致性。
Nature. 2013 Dec 19;504(7480):389-93. doi: 10.1038/nature12831. Epub 2013 Nov 27.
5
hERG inhibitors with similar potency but different binding kinetics do not pose the same proarrhythmic risk: implications for drug safety assessment.具有相似效力但结合动力学不同的人乙醚-a- go-相关基因(hERG)抑制剂不会带来相同的致心律失常风险:对药物安全性评估的启示
J Cardiovasc Electrophysiol. 2014 Feb;25(2):197-207. doi: 10.1111/jce.12289. Epub 2013 Oct 7.
6
Metrics other than potency reveal systematic variation in responses to cancer drugs.除了效价之外,其他指标也揭示了癌症药物反应的系统变异。
Nat Chem Biol. 2013 Nov;9(11):708-14. doi: 10.1038/nchembio.1337. Epub 2013 Sep 8.
7
A strategy to model nonmonotonic dose-response curve and estimate IC50.一种用于构建非单调剂量-反应曲线并估计 IC50 的策略。
PLoS One. 2013 Aug 1;8(8):e69301. doi: 10.1371/journal.pone.0069301. Print 2013.
8
Complexity vs. simplicity: groundwater model ranking using information criteria.复杂性与简单性:使用信息准则对地下水模型进行排名
Ground Water. 2014 Jul-Aug;52(4):573-83. doi: 10.1111/gwat.12080. Epub 2013 Jun 10.
9
Modeling non-monotonic dose-response relationships: model evaluation and hormetic quantities exploration.建立非单调剂量-反应关系模型:模型评估和探索有益效应量。
Ecotoxicol Environ Saf. 2013 Mar;89:130-6. doi: 10.1016/j.ecoenv.2012.11.022. Epub 2012 Dec 21.
10
Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells.紫杉醇和 CYC3(一种极光激酶 A 抑制剂)在胰腺癌细胞中协同作用,但在骨髓前体细胞中没有协同作用。
Br J Cancer. 2012 Nov 6;107(10):1692-701. doi: 10.1038/bjc.2012.450. Epub 2012 Oct 4.